The artificial pancreas: Are we there yet?

Diabetes Care

Volumn 37, Issue 5, 2014, Pages 1182-1183

  Cefalu, William T ^a   Tamborlane, William V ^b  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFICIAL PANCREAS; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CONTROL STRATEGY; DEVICE SAFETY; DIABETES CONTROL; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; HUMAN; INSULIN PUMP; MEDICAL RESEARCH; PATIENT SAFETY; TREATMENT INDICATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; INSULIN INFUSION; INSULIN RESISTANCE; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TRENDS;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN INFUSION SYSTEMS; INSULIN RESISTANCE; PANCREAS, ARTIFICIAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84899067686     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-0491     Document Type: Article

References (8)

1. Kudva YC, Carter RE, Cobelli C, Basu R, Basu A. Closed-loop artificial pancreas systems: physiological input to enhance next-generation devices. Diabetes Care 2014;37:1184-1190
2. Doyle FJ, III, Huyett LM, Lee JB, Zisser HC, Dassau E. Closed-loop artificial pancreas systems: engineering the algorithms. Diabetes Care 2014;37:1191-1197
3. Kumareswaran K, Thabit H, Leelarathna L, et al. Feasibility of closed-loop insulin delivery in type 2 diabetes: a randomized controlled study. Diabetes Care 2014;37:1198-1203
4. Hovorka R, Elleri D, Thabit H, et al. Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial. Diabetes Care 2014;37:1204-1211
5. Del Favero S, Bruttomesso D, Di Palma F, et al.; AP@home Consortium. First use of model predictive control in outpatient wearable artificial pancreas. Diabetes Care 2014;37:1212-1215
6. Schiavon M, Dalla Man C, Kudva YC, Basu A, Cobelli C. Quantitative estimation of insulin sensitivity in type 1 diabetic subjects wearing a sensor-augmented insulin pump. Diabetes Care 2014;37:1216-1223
7. Beck RW, Raghinaru D, Wadwa RP, et al.; In Home Closed Loop Study Group. Frequency of morning ketosis after overnight insulin suspension using an automated nocturnal predictive low glucose suspend system. Diabetes Care 2014;37:1224-1229
8. Sherr JL, Palau Collazo M, Cengiz E, et al. Safety of nighttime 2-hour suspension of basal insulin in pump-treated type 1 diabetes even in the absence of low glucose. Diabetes Care 2014;37:773-779